🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase Ib: To observe the safety and tolerability of the combination of SI-B...
Status
Active Not Recruiting
Location
Shanghai Pulmonary Hospital
Start Date
2023-10-30
Trial ID
NCT05949606
Phase II: To explore the efficacy, safety and tolerability of BL-B01D1+SI-B...
Status
Recruiting
Location
Chongqing University Cancer Hospital
Start Date
2024-01-29
Trial ID
NCT05956587
In phase Ia study, the safety and tolerability of SI-B003 in patients with ...
Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Start Date
2020-11-10
Trial ID
NCT04606472
Treatments Being Tested
This phase II study is designed to explore the efficacy and safety of SI-B0...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2023-12-11
Trial ID
NCT05965856
Phase Ib: To observe the safety and tolerability of SI-B001+SI-B003 in comb...
Status
Active Not Recruiting
Location
Shanghai Oriental Hospital
Start Date
2023-02-10
Trial ID
NCT05668858
This phase II study is a clinical study to explore the efficacy and safety ...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2023-12-12
Trial ID
NCT06042894
Objective: To explore the efficacy, safety and tolerability of BL-B01D1, SI...
Status
Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2023-11-06
Trial ID
NCT05990803
This phase II study is a clinical study to explore the efficacy and safety ...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2023-11-16
Trial ID
NCT06008054
Treatments Being Tested
This study is a open, multi-center phase II clinical study to explore the e...
Status
Active Not Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2024-11-07
Trial ID
NCT06668961
This phase II study is designed to investigate the efficacy and safety of B...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2023-10-20
Trial ID
NCT06006169